Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Trail of Bits showed how crafted images could manipulate systems, including Gemini CLI, Vertex AI Studio, Google Assistant on Android, and Gemini’s web interface. In one case, Google Calendar data was ...

The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.

Cerebras’s hosted Qwen3 Coder service promised to be the Claude replacement many developers craved. We’re losing hope.

Vor Biopharma has rebounded from near-delisting by securing global rights (ex-China) to telitacicept, a promising autoimmune therapy. Click here to read more.

The auto industry is flashing warning lights on the state of the U.S. economy. Automakers' profits are getting squeezed by tariffs. A subprime auto lender recently collapsed, and some car retailers ...

Ralph Lauren launches 'Ask Ralph,' an AI-powered digital stylist within its app, developed with Microsoft Azure OpenAI, ...

Acumatica has announced the general availability of its 2025 R2 ERP Platform. The R2 release features new and updated enhancements that improve usability, ...

Our annual healthcare roundtable sizes up the risks and opportunities as public policy shifts. 16 stocks to buy now.

The three-lap event, one of eight that day, was won by FC Pycroft in an unusual-looking Jaguar SS100, seeing off a small ...

Jupiter Endovascular, Inc. announced that its Vertex catheter has received FDA 510(k) clearance for the insertion of endovasc ...

Hello, today I’m going to review the Particle Tachyon SBC designed for high-performance edge AI, IoT, and connectivity ...